Clinical Trials Logo

Clinical Trial Summary

The investigators want to investigate if patients with Oculopharyngeal Muscular Dystrophy can improve fitness by home-training on a cycle ergometer 30 minute, 3 times a week for 10 weeks.

Participants will be evaluated on maximal oxygen consumption and maximal workload measured by an incremental test at baseline and at the end of the exercise period.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


NCT number NCT02158156
Study type Interventional
Source Rigshospitalet, Denmark
Contact
Status Recruiting
Phase N/A
Start date February 2014
Completion date February 2015

See also
  Status Clinical Trial Phase
Completed NCT02877784 - Screening in Oculopharyngeal Muscular Dystrophy
Recruiting NCT06185673 - A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia Phase 1/Phase 2
Enrolling by invitation NCT04009408 - Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders N/A
Recruiting NCT03874910 - Pathology Analysis of OPMD Patient Myotomies
Withdrawn NCT04226924 - Treatment of Oculopharyngeal Muscular Dystrophy With Trehalose Phase 2
Completed NCT02015481 - Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients Phase 2
Withdrawn NCT03161847 - Natural History Study of Oculopharyngeal Muscular Dystrophy